Sustainability Consulting
AstraZeneca Sustainability
Full Credential Description
AstraZeneca and H&M Group have both implemented innovative supplier engagement programs aimed at significantly reducing their scope 3 emissions, which are often the largest source of greenhouse gas emissions for companies. AstraZeneca has set an ambitious target that requires 95% of its suppliers, covering purchased goods and services, to establish science-based targets by 2025. To achieve this, AstraZeneca developed the Sustainability Champions Network, which facilitates clear communication of expectations and provides resources to support suppliers in setting their own targets. This initiative has already resulted in an 18% increase in the number of suppliers reporting emissions to CDP, a notable achievement given the historically low growth of science-based targets in the biotech and healthcare sectors.
Similarly, H&M Group has committed to a 56% reduction in absolute scope 3 emissions by 2030. The company’s supplier engagement program requires suppliers to submit emissions-reduction roadmaps, which include detailed plans for achieving their targets. H&M meets with suppliers annually to communicate requirements and offers consultations and audits to identify opportunities for emissions reductions. Additionally, H&M supports its suppliers in sourcing renewable electricity, advocating for reforms in energy markets to enhance access to sustainable energy sources. This proactive approach not only aims to decarbonize H&M's supply chain but also positions the company as a leader in sustainability within the fashion industry.
Both companies exemplify how targeted supplier engagement can create a ripple effect, encouraging suppliers to adopt science-based targets and contribute to broader climate action efforts.